hiv seropositivity

Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

---

Study Counts

Type	Study_count
Total_Studies	140
interventional	97
Observational	42
Registry	1

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type	Study_Count
Behavioral	32
Drug	32
Other	11
Device	6
Drug|placebo	4
Biological	3
Dietary Supplement	2
Behavioral|Drug	1
Behavioral|Other	1
Biological|placebo	1
Dietary Supplement|Drug	1
Drug|Other|placebo	1
placebo	1
Procedure	1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country	Study_Count
United States	45
South Africa	6
NA	5
Zambia	4
Brazil	3
Canada	3
France	3
Zimbabwe	3
Belgium	2
Mozambique	2
Spain	2
Botswana	1
Chile	1
Colombia	1
Denmark	1
Ethiopia	1
Finland	1
Greece	1
Haiti	1
Indonesia|Ukraine|Vietnam	1
Kenya	1
Mali	1
Nepal	1
Swaziland	1
Tanzania	1
Tanzania|Uganda|Zimbabwe	1
Thailand	1
Ukraine	1
United States|Puerto Rico	1
Vietnam	1

Sites per Study

Site_count	Study_Count
1	62
2	10
3	8
4	6
5	2
6	1
7	1
9	1
10	2
17	1
27	1
40	1
42	1

Phase

Phase	Study_Count
N/A	52
Phase 2	13
Phase 1	12
Phase 3	10
Phase 4	7
Phase 1/Phase 2	2
Early Phase 1	1

Number of Arms

Number_of_Arms	Count_of_Studies
1	15
2	50
3	7
4	3
6	1
NA	21

Enrollment Metrics by Phase

Measure	Early.Phase.1	N.A	Phase.1	Phase.1.Phase.2	Phase.2	Phase.3	Phase.4
Min.	23	15.00	12.00000	10.00	16.00000	20.00	44.0
1st Qu.	23	84.50	19.00000	45.25	35.00000	52.25	48.5
Median	23	215.00	26.00000	80.50	51.00000	470.50	86.0
Mean	23	534.76	37.63636	80.50	87.16667	3385.50	150.0
3rd Qu.	23	458.50	52.50000	115.75	132.50000	1246.00	184.5
Max.	23	8080.00	100.00000	151.00	223.00000	24111.00	454.0

Trial Group Type

group_type	Group_Count
Experimental	76
Active Comparator	36
No Intervention	24
NA	21
Placebo Comparator	11
Other	6
Sham Comparator	1

Intervention Model

intervention_model	Study_Count
Parallel Assignment	56
Single Group Assignment	22
NA	11
Crossover Assignment	5
Factorial Assignment	3

Primary Purpose

primary_purpose	Study_Count
Treatment	51
Prevention	17
Supportive Care	12
Health Services Research	9
Diagnostic	2
Other	2
NA	2
Basic Science	1
Screening	1

Observational Studies

Studies by Country

Country	Study_Count
United States	17
France	10
NA	4
Argentina|Brazil|Peru	1
Australia	1
Belgium	1
Brazil	1
Cambodia	1
Canada	1
Ireland|United Kingdom	1
Mali	1
Mozambique	1
South Africa|Zambia	1
United States|Kenya	1

Sites per Study

Site_count	Study_Count
1	31
2	4
3	2
4	1
6	1
8	1
12	1
15	1

Enrollment Metrics

Measure	Observational
Min	10.0000
1st Qu	50.0000
Median	160.0000
Mean	461.6829
3rd Qu	541.0000
Max	3554.0000

Observation Model

observational_model	Study_Count
Cohort	20
NA	8
Other	4
Case-Control	3
Case-Only	3
Case Control	2
Ecologic or Community	2

Time Perspective

time_perspective	Study_Count
Prospective	26
Cross-Sectional	6
NA	6
Retrospective	3
Other	1

Registries

Studies by Country

Country	Study_Count
Chile	1

Sites per Study

Site_count	Study_Count
2	1

Enrollment Metrics

Measure	Registries
Min	1200
1st Qu	1200
Median	1200
Mean	1200
3rd Qu	1200
Max	1200

Registry Model

observational_model	Study_Count
Other	1

Time Perspective

time_perspective	Study_Count
Prospective	1

Follow-up

target_duration	Study_Count
1 Year	1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id	brief_title	link	overall_status	source	primary_completion_date
NCT03374358	Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir	https://ClinicalTrials.gov/show/NCT03374358	Completed	Helsinki University Central Hospital	2019-11-02
NCT03367130	Improving Clinic Attendance for Medication Collection Among HIV Positive Individuals in Nepal	https://ClinicalTrials.gov/show/NCT03367130	Completed	Tokyo University	2018-06-30
NCT03333083	Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen	https://ClinicalTrials.gov/show/NCT03333083	Recruiting	Hospital Clinic of Barcelona	2020-03-30
NCT03311945	Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM	https://ClinicalTrials.gov/show/NCT03311945	Recruiting	Hospital Clinic of Barcelona	2020-03-30
NCT03292913	Positive Health Check Evaluation Trial	https://ClinicalTrials.gov/show/NCT03292913	Active, not recruiting	RTI International	2020-10-31
NCT03218839	Evaluation of the PrePex Device for Rapid Scale-up of VMMC, Phase 3 Field Implementation Trial With HIV + Adult Males	https://ClinicalTrials.gov/show/NCT03218839	Completed	University of Washington	2016-02-29
NCT03213028	Family Planning Service Delivery Integration For HIV Positive And At-Risk Women In Botswana: A Hybrid Type 2 Clinical Intervention And Implementation Strategy	https://ClinicalTrials.gov/show/NCT03213028	Completed	University of Pennsylvania	2018-08-10
NCT03134924	Vaginal Practices in Human Immunodeficiency Virus (HIV) Positive Women in Zambia, a Bio-Behavioral Intervention “WASH-2”	https://ClinicalTrials.gov/show/NCT03134924	Completed	University of Miami	2014-02-05
NCT03124914	Relationship Between Neuromuscular Fatigue, Perceived Tiredness and Level Of Physical Activity of Patients Living With HIV	https://ClinicalTrials.gov/show/NCT03124914	Completed	Centre Hospitalier Universitaire de Nice	2018-04-19
NCT03073421	Positive Pregnancy Program	https://ClinicalTrials.gov/show/NCT03073421	Completed	St. Michael’s Hospital, Toronto	2016-09-01
NCT03004170	Telephone Counseling to Enhance the Quality and Safety of Romantic and Sexual Relationships in People Living and Aging With HIV	https://ClinicalTrials.gov/show/NCT03004170	Active, not recruiting	Oregon Health and Science University	2020-12-31
NCT02994329	Community-based Distribution of Oral HIV Self-testing Kits	https://ClinicalTrials.gov/show/NCT02994329	Completed	Zambart	2017-09-30
NCT02938377	Alcohol Research Consortium in HIV-Intervention Research Arm	https://ClinicalTrials.gov/show/NCT02938377	Recruiting	University of Alabama at Birmingham	2021-08-31
NCT02935296	Integrated Treatment and Prevention for People Who Inject Drugs	https://ClinicalTrials.gov/show/NCT02935296	Completed	HIV Prevention Trials Network	2017-06-16
NCT02921516	Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings	https://ClinicalTrials.gov/show/NCT02921516	Completed	Florida International University	2018-05-31
NCT02833441	The Peer Support Intervention - Supporting HIV Positive Adolescents in Zimbabwe to Improve HIV Care Continuum Outcomes	https://ClinicalTrials.gov/show/NCT02833441	Completed	University of Zimbabwe	2018-03-31
NCT02689895	Etiology of Treatment Failure in HIV Positive Children and Adolescents on Boosted Protease Inhibitor-based Regimens	https://ClinicalTrials.gov/show/NCT02689895	Completed	University of Zimbabwe	2017-01-31
NCT02677675	Effectiveness of Mobile Phone Technology on Adherence and Treatment Outcomes Among HIV Positive Patients on ART	https://ClinicalTrials.gov/show/NCT02677675	Completed	Universiti Putra Malaysia	2014-12-31
NCT02676167	Public Health Targeting of PrEP at HIV Positives’ Bridging Networks	https://ClinicalTrials.gov/show/NCT02676167	Completed	University of Chicago	2019-05-31
NCT02590354	Analytical Treatment Interruption in HIV Positive Patients	https://ClinicalTrials.gov/show/NCT02590354	Completed	Institute of Tropical Medicine, Belgium	2018-06-22
NCT03397420	Family-centered HIV Care, Viral Suppression and Retention in HIV-positive Children, Swaziland	https://ClinicalTrials.gov/show/NCT03397420	Completed	Elizabeth Glaser Pediatric AIDS Foundation	2018-10-30
NCT02546271	A Small-group Intervention to Reduce HIV Sexual Transmission Risk Behavior Among HIV-positive Men Who Have Sex With Men	https://ClinicalTrials.gov/show/NCT02546271	Completed	Ryerson University	2013-11-30
NCT02535429	Massage Therapy for HIV-positive People : Effects on Anxiety, Depression, Hyperventilation and Quality of Life	https://ClinicalTrials.gov/show/NCT02535429	Completed	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	2015-12-31
NCT02371265	Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique	https://ClinicalTrials.gov/show/NCT02371265	Completed	University of Washington	2015-08-31
NCT02338024	Enhancing Linkage to HIV Care for Newly Detected HIV-positive Persons in Ukraine	https://ClinicalTrials.gov/show/NCT02338024	Completed	Ukrainian Institute on Public Health Policy	2017-10-03
NCT02190643	Improving Nicotine Patch Adherence Among Latino HIV-Positive Smokers	https://ClinicalTrials.gov/show/NCT02190643	Completed	RAND	2015-11-30
NCT02153788	Efficacy and Safety of Temazepam in HIV Seropositive Patients With Insomnia	https://ClinicalTrials.gov/show/NCT02153788	Completed	Duke University	2010-09-30
NCT01296113	Chemotherapy for Lung Cancer in HIV-positive Patients	https://ClinicalTrials.gov/show/NCT01296113	Completed	Intergroupe Francophone de Cancerologie Thoracique	2016-01-31
NCT01295034	Vitamin D Supplements for HIV-positive Patients on cART	https://ClinicalTrials.gov/show/NCT01295034	Completed	Icahn School of Medicine at Mount Sinai	2015-06-30
NCT02029430	A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi’s Sarcoma	https://ClinicalTrials.gov/show/NCT02029430	Completed	CytRx	2015-12-31
NCT02012556	Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients	https://ClinicalTrials.gov/show/NCT02012556	Completed	Theratechnologies	2008-07-31
NCT02011958	Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.	https://ClinicalTrials.gov/show/NCT02011958	Completed	Drugs for Neglected Diseases	2016-08-31
NCT01957917	Comparing Food and Cash Assistance for HIV-Positive Men and Women on Antiretroviral Therapy in Tanzania	https://ClinicalTrials.gov/show/NCT01957917	Completed	University of California, Berkeley	2016-10-31
NCT01941121	CCTG 593: Testing and Linkage to Care	https://ClinicalTrials.gov/show/NCT01941121	Active, not recruiting	University of California, San Diego	2018-01-22
NCT01910493	Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique	https://ClinicalTrials.gov/show/NCT01910493	Completed	Absolute Return for Kids	2013-05-31
NCT01898754	Oligonucleotide Ligation Assay (OLA) Resistance Study	https://ClinicalTrials.gov/show/NCT01898754	Completed	University of Washington	2016-12-31
NCT01881971	Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center	https://ClinicalTrials.gov/show/NCT01881971	Completed	University of Pittsburgh	2015-11-30
NCT01818258	IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children	https://ClinicalTrials.gov/show/NCT01818258	Completed	International Maternal Pediatric Adolescent AIDS Clinical Trials Group	2017-04-11
NCT01816828	Intervention Research to Reduce HIV Sexual Transmission Among HIV Positive Men Who Have Sex With Men	https://ClinicalTrials.gov/show/NCT01816828	Completed	Ryerson University	2018-08-31
NCT01751620	Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care	https://ClinicalTrials.gov/show/NCT01751620	Completed	University of North Carolina, Chapel Hill	2015-06-30
NCT01733927	An Evaluation of a Rapid Test for HIV	https://ClinicalTrials.gov/show/NCT01733927	Completed	Pontificia Universidad Catolica de Chile	2010-11-30
NCT01723956	Validation of Implementation of Cervical Dysplasia Treatment Modalities in HIV-Seropositive Women	https://ClinicalTrials.gov/show/NCT01723956	Completed	University of Witwatersrand, South Africa	2014-08-31
NCT01721798	Comparison of Two IUDs Among Cape Town HIV-positive Women	https://ClinicalTrials.gov/show/NCT01721798	Completed	FHI 360	2018-07-13
NCT01689545	Prevention for Positives: An RCT Among Vietnamese HIV-positive IDU	https://ClinicalTrials.gov/show/NCT01689545	Completed	Johns Hopkins Bloomberg School of Public Health	2013-04-30
NCT01537367	Intervention to Retain HIV-positive Patients in Medical Care	https://ClinicalTrials.gov/show/NCT01537367	Completed	Centers for Disease Control and Prevention	2012-02-29
NCT01499706	Telephone-delivered Behavioral Interventions to Reduce Risky Sexual Behavior in HIV-positive Late Middle-age and Older Adults	https://ClinicalTrials.gov/show/NCT01499706	Completed	Ohio University College of Osteopathic Medicine	2010-10-31
NCT01354210	Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth	https://ClinicalTrials.gov/show/NCT01354210	Completed	Ann & Robert H Lurie Children’s Hospital of Chicago	2013-03-31
NCT01350544	Treatment Advocacy Intervention for HIV-Positive African Americans	https://ClinicalTrials.gov/show/NCT01350544	Completed	Boston Children’s Hospital	2015-07-31
NCT04124536	Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women	https://ClinicalTrials.gov/show/NCT04124536	Recruiting	University of North Carolina, Chapel Hill	2021-01-31
NCT03858478	Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FAST	https://ClinicalTrials.gov/show/NCT03858478	Recruiting	Institut de Médecine et d’Epidémiologie Appliquée - Fondation Internationale Léon M’Ba	2021-03-31
NCT03531749	Antioxidant in Patients HIV+ Supplemented With Microencapsulated of Red Pomegranate	https://ClinicalTrials.gov/show/NCT03531749	Completed	Universidad Autónoma del Estado de Hidalgo	2017-05-31
NCT03517358	Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol	https://ClinicalTrials.gov/show/NCT03517358	Recruiting	University of California, Davis	2019-12-31
NCT03483857	Peer Navigation to Improve Engagement in Care for HIV-Positive Men Who Have Sex With Men in Ehlanzeni, South Africa	https://ClinicalTrials.gov/show/NCT03483857	Completed	University of California, San Francisco	2018-06-29
NCT03432819	A Pilot Intervention to Improve Coping With Discrimination and Adherence Among HIV-Positive Latino MSM	https://ClinicalTrials.gov/show/NCT03432819	Active, not recruiting	RAND	2020-08-31
NCT01246401	Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations	https://ClinicalTrials.gov/show/NCT01246401	Completed	Yale University	2016-03-31
NCT01211288	Longitudinal Study of Dental Implant Therapy in HIV Positive Patients	https://ClinicalTrials.gov/show/NCT01211288	Completed	University of Alabama at Birmingham	2019-04-01
NCT01174914	Effectiveness Study Low-Dose Naltrexone Versus ARV’s for HIV+	https://ClinicalTrials.gov/show/NCT01174914	Completed	The Ojai Foundation	2010-03-31
NCT01140880	Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men	https://ClinicalTrials.gov/show/NCT01140880	Completed	Friends Research Institute, Inc.	2013-03-31
NCT01122186	Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men (ACE)	https://ClinicalTrials.gov/show/NCT01122186	Completed	Hunter College of City University of New York	2012-01-31
NCT00990678	Study of Vitamin D Supplementation to Male HIV Sero-positive Patients	https://ClinicalTrials.gov/show/NCT00990678	Completed	Hvidovre University Hospital	2010-02-28
NCT00959361	Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy	https://ClinicalTrials.gov/show/NCT00959361	Completed	Hospital de Clinicas de Porto Alegre	2009-05-31
NCT00941889	The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata	https://ClinicalTrials.gov/show/NCT00941889	Completed	Washington University School of Medicine	2011-07-31
NCT01957748	CCTG 594: Engagement and Retention in Care for HIV+	https://ClinicalTrials.gov/show/NCT01957748	Active, not recruiting	University of California, San Diego	2017-12-15
NCT01751594	Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex With Men	https://ClinicalTrials.gov/show/NCT01751594	Completed	University of North Carolina, Chapel Hill	2014-06-30
NCT00741637	Safety and Immunogenicity of Single Dose Choleragarde® in HIV-Seropositive Adults	https://ClinicalTrials.gov/show/NCT00741637	Completed	International Vaccine Institute	2011-04-30
NCT00721305	Lovastatin: Immunomodulatory Value Evaluation	https://ClinicalTrials.gov/show/NCT00721305	Completed	Universidad de Antioquia	2011-07-31
NCT00686205	Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay	https://ClinicalTrials.gov/show/NCT00686205	Completed	Abbott Diagnostics Division	2008-08-31
NCT00659971	Phase 2B Dose-Ranging Study of PAC113 Mouthrinse in HIV Seropositive Individuals With Oral Candidiasis	https://ClinicalTrials.gov/show/NCT00659971	Completed	Pacgen Biopharmaceuticals Corporation	2008-06-30
NCT00551720	Motivation and Patch Treatment for HIV-positive Smokers	https://ClinicalTrials.gov/show/NCT00551720	Completed	National Institute on Drug Abuse (NIDA)	NA
NCT00444977	Enhancing Oral Health Care Use by HIV Positive Individuals	https://ClinicalTrials.gov/show/NCT00444977	Completed	Columbia University	2009-12-31
NCT00429845	Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized Trial	https://ClinicalTrials.gov/show/NCT00429845	Completed	Hospital de Clinicas de Porto Alegre	NA
NCT00381212	A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent.	https://ClinicalTrials.gov/show/NCT00381212	Completed	McGill University Health Centre/Research Institute of the McGill University Health Centre	2008-02-29
NCT00367458	Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy	https://ClinicalTrials.gov/show/NCT00367458	Completed	National Institutes of Health Clinical Center (CC)	2008-06-19
NCT00343317	Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women	https://ClinicalTrials.gov/show/NCT00343317	Completed	University of KwaZulu	NA
NCT00270530	Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia	https://ClinicalTrials.gov/show/NCT00270530	Completed	Center for International Health and Development	NA
NCT00213083	Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission	https://ClinicalTrials.gov/show/NCT00213083	Completed	Population Council	2007-04-30
NCT00213005	Safety and Acceptability of Carraguard® in HIV Positive Women and Men	https://ClinicalTrials.gov/show/NCT00213005	Completed	Population Council	NA
NCT00197678	Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women	https://ClinicalTrials.gov/show/NCT00197678	Completed	Harvard School of Public Health	2005-07-31
NCT00130819	Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants	https://ClinicalTrials.gov/show/NCT00130819	Completed	Johns Hopkins University	2009-04-30
NCT00116636	Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients	https://ClinicalTrials.gov/show/NCT00116636	Completed	Therapeutic Concepts	NA
NCT00086710	Study of Enfuvirtide in HIV-Positive Subjects	https://ClinicalTrials.gov/show/NCT00086710	Completed	Trimeris	NA
NCT00035893	The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART	https://ClinicalTrials.gov/show/NCT00035893	Completed	AIM ImmunoTech Inc.	2006-08-31
NCT00447798	Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users	https://ClinicalTrials.gov/show/NCT00447798	Completed	Columbia University	2011-03-31
NCT00009555	Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat	https://ClinicalTrials.gov/show/NCT00009555	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00002321	A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis	https://ClinicalTrials.gov/show/NCT00002321	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002243	A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never Received Anti-HIV Treatment	https://ClinicalTrials.gov/show/NCT00002243	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002171	A Study of Viracept in HIV-Positive Women	https://ClinicalTrials.gov/show/NCT00002171	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002098	Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2’,3’-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients	https://ClinicalTrials.gov/show/NCT00002098	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00002033	A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease	https://ClinicalTrials.gov/show/NCT00002033	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00001997	Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals	https://ClinicalTrials.gov/show/NCT00001997	Completed	NIH AIDS Clinical Trials Information Service	NA
NCT00000772	A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals	https://ClinicalTrials.gov/show/NCT00000772	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00000735	A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC	https://ClinicalTrials.gov/show/NCT00000735	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00000667	A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells	https://ClinicalTrials.gov/show/NCT00000667	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00000664	Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals	https://ClinicalTrials.gov/show/NCT00000664	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00000648	A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals	https://ClinicalTrials.gov/show/NCT00000648	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00000633	A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals	https://ClinicalTrials.gov/show/NCT00000633	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00001474	Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients	https://ClinicalTrials.gov/show/NCT00001474	Completed	National Institutes of Health Clinical Center (CC)	NA

Observational Studiess

#If less then 500 studies

nct_id	brief_title	link	overall_status	source	primary_completion_date
NCT04030689	Free HIV Testing in Private Biological Laboratories: A New Offer to Encourage HIV Testing	https://ClinicalTrials.gov/show/NCT04030689	Recruiting	Centre Hospitalier Universitaire de Nice	2020-06-30
NCT03369743	Dual Therapy Etravirine + Raltegravir by Once Daily in HIV-positive Patients (ETRAL QD)	https://ClinicalTrials.gov/show/NCT03369743	Completed	Centre de Recherches et d’Etude sur la Pathologie Tropicale et le Sida	2018-06-30
NCT03290755	Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux	https://ClinicalTrials.gov/show/NCT03290755	Completed	University Hospital, Bordeaux	2018-03-13
NCT03215004	Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals	https://ClinicalTrials.gov/show/NCT03215004	Recruiting	American Gene Technologies International Inc.	2021-02-07
NCT03170414	Observational Study of Solid Organ Transplantation Utilizing HIV-Positive Donors in HIV-Positive Recipients	https://ClinicalTrials.gov/show/NCT03170414	Recruiting	University of Minnesota	2022-12-31
NCT03139630	COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV—Infected Patients	https://ClinicalTrials.gov/show/NCT03139630	Completed	Saint Antoine University Hospital	2016-09-30
NCT03030768	Safer Conception Intervention for HIV-1 Serodiscordant Couples	https://ClinicalTrials.gov/show/NCT03030768	Completed	University of Washington	2018-05-31
NCT02154971	Assessment of Age-related Hearing Loss in HIV-1 Patients	https://ClinicalTrials.gov/show/NCT02154971	Active, not recruiting	Fondation Ophtalmologique Adolphe de Rothschild	2019-02-26
NCT02116374	Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients	https://ClinicalTrials.gov/show/NCT02116374	Completed	French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)	2016-06-30
NCT02082574	Prevalence of Cerebral Small Vessel Disease in HIV Infected Patients	https://ClinicalTrials.gov/show/NCT02082574	Completed	Fondation Ophtalmologique Adolphe de Rothschild	2016-06-30
NCT01311752	Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women	https://ClinicalTrials.gov/show/NCT01311752	Completed	French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)	2012-11-30
NCT02003989	Revealing Increased Axonal Loss in Treated HIV Patients	https://ClinicalTrials.gov/show/NCT02003989	Completed	Fondation Ophtalmologique Adolphe de Rothschild	2015-08-31
NCT01824628	Comparison of the QT/QTc Interval Between an Outpatient HIV-Infected Population on Antiretroviral Therapy and Two Large HIV-Negative Cohorts	https://ClinicalTrials.gov/show/NCT01824628	Completed	Centre hospitalier de l’Université de Montréal (CHUM)	2013-10-31
NCT01813292	Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine	https://ClinicalTrials.gov/show/NCT01813292	Completed	Hopital Lariboisière	2014-05-31
NCT01748136	Screening for Lung Cancer in the HIV Patient	https://ClinicalTrials.gov/show/NCT01748136	Completed	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	2011-09-30
NCT01737047	The Effects of Ageing on the ‘Pharmacokinetic and Clinical Observations in People Over Fifty’	https://ClinicalTrials.gov/show/NCT01737047	Active, not recruiting	Imperial College London	2021-01-31
NCT01701895	Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera	https://ClinicalTrials.gov/show/NCT01701895	Completed	University of North Carolina, Chapel Hill	2015-10-31
NCT01681914	Assessment of the Effectiveness of New Clinical Guidelines for Differential Diagnosis and Management of Common HIV/AIDS-related Conditions in Mozambique	https://ClinicalTrials.gov/show/NCT01681914	Completed	Vanderbilt University	2012-09-30
NCT01536912	Medical Marijuana Use in HIV+ Patients: Probability Survey	https://ClinicalTrials.gov/show/NCT01536912	Completed	Wayne State University	2014-12-31
NCT01536899	Medical Marijuana Use in HIV+ Patients Prospective Cohort Study	https://ClinicalTrials.gov/show/NCT01536899	Completed	Wayne State University	2017-06-30
NCT04044586	HIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, and Unsafe Injection Practices (12352 ANRS ROK INVEST)	https://ClinicalTrials.gov/show/NCT04044586	Active, not recruiting	French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)	2019-09-30
NCT03795415	ANRS12373 GUNDO SO - Evaluation of an Empowerment Program for WLHIV in Mali	https://ClinicalTrials.gov/show/NCT03795415	Recruiting	French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)	2020-02-29
NCT03777371	Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation	https://ClinicalTrials.gov/show/NCT03777371	Completed	Kanuni Sultan Suleyman Training and Research Hospital	2018-12-01
NCT03721796	Cancer Treatment Decision-making in the HIV Population: an Observational Study of Physician-patient Interactions	https://ClinicalTrials.gov/show/NCT03721796	Active, not recruiting	Duke University	2023-11-30
NCT03449706	Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection	https://ClinicalTrials.gov/show/NCT03449706	Recruiting	University Hospital, Ghent	2023-01-01
NCT01154556	RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice	https://ClinicalTrials.gov/show/NCT01154556	Completed	Holdsworth House Medical Practice	2011-09-30
NCT01154543	Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes	https://ClinicalTrials.gov/show/NCT01154543	Completed	Holdsworth House Medical Practice	2013-01-31
NCT01152684	Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border	https://ClinicalTrials.gov/show/NCT01152684	Completed	University of California, San Diego	2013-01-31
NCT01034800	The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215	https://ClinicalTrials.gov/show/NCT01034800	Completed	National Institutes of Health Clinical Center (CC)	NA
NCT00981279	Profile of HIV Seropositive Patients	https://ClinicalTrials.gov/show/NCT00981279	Completed	Universidade Federal de Goias	2009-09-30
NCT00857350	The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment	https://ClinicalTrials.gov/show/NCT00857350	Completed	Yale University	2010-06-30
NCT01875588	Thinking and Memory Problems in People With HIV	https://ClinicalTrials.gov/show/NCT01875588	Recruiting	National Institutes of Health Clinical Center (CC)	2027-02-22
NCT01793467	Transplantation and the Use of Raltegravir in HIV-Infected Patients	https://ClinicalTrials.gov/show/NCT01793467	Completed	Duke University	2017-06-30
NCT03920969	Sport and Self Esteem in Patients Living With HIV	https://ClinicalTrials.gov/show/NCT03920969	Recruiting	Centre Hospitalier le Mans	2019-11-30
NCT00639145	Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol	https://ClinicalTrials.gov/show/NCT00639145	Completed	Elizabeth Glaser Pediatric AIDS Foundation	2012-12-31
NCT00341302	A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries	https://ClinicalTrials.gov/show/NCT00341302	Completed	National Institutes of Health Clinical Center (CC)	NA
NCT00271882	PTSD and Risk Behavior in HIV Positive Female Adolescents	https://ClinicalTrials.gov/show/NCT00271882	Completed	University of North Carolina, Chapel Hill	2006-09-30
NCT00245531	Effects of Endocrine Health on Mental Performance of Men and Women Using Drugs	https://ClinicalTrials.gov/show/NCT00245531	Completed	Johns Hopkins University	2010-06-30
NCT00106795	Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS	https://ClinicalTrials.gov/show/NCT00106795	Completed	National Institutes of Health Clinical Center (CC)	NA
NCT00001102	The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive Patients	https://ClinicalTrials.gov/show/NCT00001102	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	NA
NCT00006171	Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma	https://ClinicalTrials.gov/show/NCT00006171	Completed	National Institutes of Health Clinical Center (CC)	NA
NCT00012701	Measuring HIV Quality of Care	https://ClinicalTrials.gov/show/NCT00012701	Completed	VA Office of Research and Development	NA

Registries

#If less then 500 registries

nct_id	brief_title	link	overall_status	source	primary_completion_date
NCT04088916	Proviral DNA as a Target for HIV-1 Resistance Analysis	https://ClinicalTrials.gov/show/NCT04088916	Recruiting	University of Chile	2019-09-08